Resources for Doctors

APASL STC Lectures 2

TitleAuthors
A Rational Evidence-based Approach to Abnormal Liver TestsJane D. Ricaforte-Campos, MD FPCP, FPSG, FPSDE
AASLD Guidelines and HCC: US based commentaryRobert G Gish MD
ACUTE ON CHRONIC LIVER FAILUREJuliet L. Gopez-Cervantes MD
Advances in HCV Treatment: Beyond Triple TherapyJacob George
Alcohol, Environment and HCCByung Chul Yoo MD PhD
Alcoholic Liver Disease: What are the treatment options?Joseph C. Bocobo MD
APASL and CEVHAP Partnership: a Hepatitis-Free WorldDr Locarnini Dr Wallace
APASL and CEVHAP Partnership: Its Vision for Hepatitis-free World Darrell HG Crawford MD FRACP
APASL and CEVHAP Partnership: Its Vision for Hepatitis-free WorldDr John Wallac
APASL Guideline on HCCMasatoshi Kudo MD PhD
ASCITES AND HYPONATREMIA IN LIVER CIRRHOSIS: HOW AND WHEN TO INTERVENEJudy Lao-Tan, MD FPCP FPSG FPSDE
Assessment of Resectability of HCCMa. Vanessa H de Villa MD PhD
CE-Ultrasound US Elastography for HCCByung Ihn Choi M.
Challenges in diagnosis of hepatocellular carcinomaDo Young Kim
CLINICAL PRACTICE GUIDELINES: PARADIGMS IN MANAGEMENT OF HCC EASL-EORTC GuidelinesBruno Sangro
Clinical Staging for Hepatocellular Carcinoma: Eastern PerspectivesOsamu Yokosuka MD
Clinical Staging of HCC: A Western PerspectiveW Ray Kim MD
Combination of Transarterial Locoregional Therapy with Systemic TherapyJanus Ong MD MPH
Comparison of efficacy between hepatic arterial infusion chemotherapy and sorafenibSi Hyun Bae
Current Challenges in Systemic Therapy for Hepatocellular CarcinomaAnn-Lii Cheng MD PhD
Estimation of Prognosis and Candidacy for Liver TransplantationAllan M Concejero MD
Evaluation and Management of the Surgical Patient with Cirrhosis: Understanding and Justifying the RiskDr Eternity D Labio FPCP FPSG FPSDE
Evolving Concepts and Strategies in Liver Transplantation for Hepatocellular CarcinomaChung Mau Lo
Evolving Experience with SIRT in the PhilippinesMa. Vanessa H de Villa MD PhD
Genomics in HCC Implications for Diagnosis and TreatmentLewis R Roberts MB ChB PhD
HBsAg Quantification: Should It be Part of The Treatment Algorithm for CHB?Stephen N. Wong, MD
HBV related HCC: The role of antiviral therapy in its prevention and management – ETV real world experienceDr Grace Lai-Hung Wong MBChB (Hons, CUHK), MD (CUHK), FRCP(Edin), FHKCP, FHKAM
HCC in 3D Dimension Direction DecisionMasao Omata
HEPATIC ENCEPHALOPATHY Are we doing any better?Evelyn B. Dy, M.D.
Hepatocellular Carcinoma Screening and Surveillance StrategiesDiana Alcantara-Payawal, M.D. FPCP, FPSG, FPSDE
HIV coinfection and HCCGeorge KK Lau, MD
How do you optimize HCV Treatment for Cirrhotic PatientsSeng Gee Lim
ICG Fluorescence ImagingTakeaki ISHIZAWA and Norihiro KOKUDO
Immunizations and Medication Use in Cirrhosis: Which, How and WhenFernando V. Ona, MD, FACG
Immunotherapy for HCCJack R. Wands, MD
Infectious complications in patients with cirrhosis: What shall we do?Jenny Lim Limquiaco, MD
Innovations in HCC Imaging: MDCT/MRIAnthony E. Cheng, M.D.
Is there a role for Peg-Interferon add-on or switch therapy in patients on long term Nucleoside therapy?Prof. Teerha Piratvisuth
Long-term Efficacy and Safety of Nucleos/tide AnaloguesProfessor CL Lai
Management of CHC G1 patients who are relapsers or non-responders to Peg IFN and RBV therapy: Wait or Triple Therapy?Teerha Piratvisuth
Management of Chronic Hepatitis B: Why we care and how to treat?Prof. Khin Maung Win
Management of HCV in patients co-infected with HIVRobert Gish MD
Management of Intermediate Stage HCCMasatoshi Kudo, MD, PhD
Management of Treatment-Nai?ve G1 Patients with F1 Fibrosis: Treat Now or Wait?W. Ray Kim, MD
Metabolic Syndrome and HCCJacob George
Molecular Classification of HCCMichiie Sakamoto MD, PhD
NAFLD: Does Anything Help at all?Prof. ALAAELDIN IBRAHIM (MD)
Novel prognostic biomarkers for hepatocellular carcinomaDo Young Kim
Nutrition in CirrhosisAngela D. Salvaña, MD
Ongoing Clinical Trials in Hepatocellular CarcinomaPierce K.H Chow MD PhD
Optimal Therapy for Genotype non-1 in Asia Pacific?Dr Saeed Hamid
Pathological Classification of Hepatocellular CarcinomaGlenda Lyn Y. Pua, M.D.
Percutaneous Urtrasound-Guided Radiofrequency Ablation for Extrahepatic NeoplasmsS Sato, T Kawai, S Obi
Playing the Long Game: Can We Reach the Ultimate Goal of CHB Therapy?Jose D Sollano
Real-world Outcomes with Long-term CHB ManagementDiana A. Payawal, MD
Role of Antivirals in HBV-related HCCCL Lai
Role of Antivirals in HBV-related HCCProfessor Darrell HG Crawford MD FRACP
Role of Antivirals in the Prevention of Hepatocellular Carcinoma in Patients with Chronic HepatitisLaurentius A. Lesmana
Role of Biopsy in the Era of Targeted TherapyRyosuke Tateishi, MD, PhD
Role of PET/CT in Hepatocellular CarcinomaDr. Thomas K.C.Cheng
Selective Internal Radiation TherapyJefferson R. Pagsisihan, MD, DPSNM
SETTING THE STAGE : Understanding the pathogenesis of hepatic fibrosis and portal hypertensionJade D. Jamias, MD, FPCP, FPSG,FPSDE
Should all genotype 1 patients be started on triple therapy in Asia-Pacific?George KK Lau
Should Elderly CHC Patients (>70 years old) be Treated?Deepak Amarapurkar
SIRT for Intermediate and Advanced HCCBruno Sangro
SIRT for liver cancerDr. Stephen L. Chan
Stem Cell Therapy for HCCLewis R. Roberts, MB ChB, PhD
SURVIVAL ANALYSIS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA : IMPLICATIONS OF PATIENT CHARACTERISTICS AND MODE OF TREATMENTArl Ann S. Mendoza-Manzo, PM Villareal, RE Carpio, MM Chan, CD Dalupang, AE Ismael, JD Sollano, SN Wong
Targeted Radiation Therapy for HCCHee Chul Park
The Epidemiology of Hepatocellular Carcinoma in the Asia PacificJose D Sollano, MD
The Management of Advanced Stage Hepatocellular CarcinomaPierce K.H Chow MD PhD
Therapeutic Response Assessment and Endpoints in HCCRonnie T.P. Poon, MBBS, MS, PhD
Variceal Bleeding: To Band, Block, or TIPS?ALBERT E. ISMAEL, MD
Viral Hepatocarcinogensis and Signaling PathwaysJack R. Wands, MD
What's on the Horizon for Treatment for CHB? New Targets for HBV?Professor Stephen Locarnini
When patients fail on molecular targeted therapy: what to do in 2013Dr. Stephen L. Chan
Where East Meets West Search for a cureRobert G Gish MD